Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04604665
Other study ID # 844-2019
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 10, 2021
Est. completion date December 10, 2023

Study information

Verified date January 2024
Source Fundación Cardioinfantil Instituto de Cardiología
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

PENFUP FASE 2, It is a multicenter study by parallel conglomerates, planned in order to evaluate the efficacy between two levels of frequency of postural change in intensive care units for adults of hospitals in various regions of Colombia.


Description:

Taking into account a design effect of 6.7, Investigators planned to include 150 participants from each ICU. Investigators did calculate that a total of 22 ICUs are required, in which 11 will be assigned to the low frequency and 11 will be assigned to a high frequency group of postural change until obtaining a total of 1,650 patients in each arm of the study and a total of 3,300 participants in the study.


Recruitment information / eligibility

Status Completed
Enrollment 3300
Est. completion date December 10, 2023
Est. primary completion date December 10, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - The ICU manage adult patients, over 18 years of age, with any type of emphasis (surgical, medical, neurological, or mixed); - Patients are admitted in critical condition (with life support); - The director accepts the commitment of the care assigned in the randomization (for a period of 3 months). Exclusion Criteria: - Intermediate care units in which patients mobilize themselves. - Covid patients or other patients exposed to different mobilization patterns (e.g., 12 hours prone vs 12 supine)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
High frequency postural change
Repositioning of patients hospitalized in bed in intensive care units will be carried out with a frequency interval that we call "high-frequency" to be performed on each patient between an interval between less than or equal to every 2 hours in a full day (24 hours) (minimum goal of 8-10 in 24 hours subtracting 2 or 4 at night and not alter the circadian cycle). The position must be modified in each postural change to right lateral, supine, left lateral, or prone to supine if the position changes every 2 hrs.
Conventional care
Repositioning of patients hospitalized will be performed in the current way it is commonly applied to patients.

Locations

Country Name City State
Colombia Hospital Central Barranquilla Barranquilla Atlántico
Colombia Hospital Universitario Norte Barranquilla Barranquilla
Colombia Centro Policlínico de Olaya Bogotá Cundinamarca
Colombia Clínica de Occidente Bogotá
Colombia Clinica Nogales Bogotá Cundinamarca
Colombia Clínica Palermo Bogotá Bogotá D.C
Colombia Clínica SHAIO Bogotá
Colombia Fundación CardioInfantil Instituto de Cardiología Bogotá Cundinamarca
Colombia Hospital Militar Central Bogotá Bogotá D.C
Colombia Hospital San José Bogotá Bogotá D.C
Colombia Hospital Universitario La Samaritana Bogotá
Colombia Clìnica FOSCAL Internacional Bucaramanga
Colombia Clìnica Foscal_Carlos Ardila lulle Bucaramanga
Colombia Fundación Cardiovascular Bucaramanga Bucaramanga Santander
Colombia International Hospital of Colombia -HIC Bucaramanga Santander
Colombia Hospital Erasmo Meoz Cúcuta Norte De Santander
Colombia Hospital Federico Lleras Acosta Ibagué Tolima
Colombia S.E.S Hospital Universitario de Caldas Manizales Caldas
Colombia Hospital IPS Universitaria Medellín Antioquia
Colombia Hospital San Vicente de Paul Medellín Antioquia
Colombia Hospital San Vicente_RioNegro Rionegro Antioquia

Sponsors (2)

Lead Sponsor Collaborator
Fundación Cardioinfantil Instituto de Cardiología Universidad Autónoma de Bucaramanga

Country where clinical trial is conducted

Colombia, 

References & Publications (5)

Burk RS, Grap MJ. Backrest position in prevention of pressure ulcers and ventilator-associated pneumonia: conflicting recommendations. Heart Lung. 2012 Nov-Dec;41(6):536-45. doi: 10.1016/j.hrtlng.2012.05.008. Epub 2012 Jul 21. — View Citation

Eldridge S., Kerry S. Designing interventions in: A practical guide to cluster randomized trials in health services research. Page 44-57. Centre for Primary Care and Public Health, Barts, and The London School of Medicine and Dentistry, Queen Mary University of London UK. 2012 John Wiley & Sons, Ltda.

Gillespie BM, Chaboyer WP, McInnes E, Kent B, Whitty JA, Thalib L. Repositioning for pressure ulcer prevention in adults. Cochrane Database Syst Rev. 2014 Apr 3;2014(4):CD009958. doi: 10.1002/14651858.CD009958.pub2. — View Citation

Hawkins S, Stone K, Plummer L. An holistic approach to turning patients. Nurs Stand. 1999 Oct 6-12;14(3):51-6. doi: 10.7748/ns1999.10.14.3.51.c2689. — View Citation

Ulrika Källman. (2015). Evaluation of Repositioning in Pressure Ulcer Prevention. Linköping University Medical Dissertations No. 1455. Division of Nursing science Department of Medical and Health Sciences. Linköping University, Sweden.

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence (incidence rata ration) of new pressure ulcers in each Intensive Care Unit (ICU) The number of pressure injuries at any stage, new acquired in the ICU after admission per 1,000 patient days in the ICU. " 1 month after admission"
Secondary Risk index (HR) and time to event of Pressure ulcers of the patients Hazard ratio and tiem to event of PUs of patients included in the repositioning group with the lowest frequency compared to the group of patients included by intervention group in the development of the first PU during their stay in the ICU. "1 month safter admission"
Secondary Security outcomes Secondary safety outcomes: includes possible complications associated with postural changes: permanent or sporadic changes in ventilatory parameters (hypoxemia), hemodynamic changes (tachycardia, hypertension); events such as acute respiratory failure; or cardiogenic shock, pneumonia. "1 month after admission"
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT03671447 - Enhanced Recovery After Intensive Care (ERIC) N/A
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Completed NCT04239209 - Effect of Intensivist Communication on Surrogate Prognosis Interpretation N/A
Completed NCT05531305 - Longitudinal Changes in Muscle Mass After Intensive Care N/A
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT02916004 - The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients. N/A
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04479254 - The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study) N/A
Recruiting NCT04475666 - Replacing Protein Via Enteral Nutrition in Critically Ill Patients N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Withdrawn NCT04043091 - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Completed NCT02899208 - Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients? N/A
Completed NCT03048487 - Protein Consumption in Critically Ill Patients
Recruiting NCT02163109 - Oxygen Consumption in Critical Illness